Global Inferior Vena Cava (IVC) Filter Industry: Key Statistics and Insights in 2024-2032

Summary:

• The global inferior vena cava (IVC) filter market size reached USD 717.0 Million in 2023.
• The market is expected to reach USD 1,371.1 Million by 2032, exhibiting a growth rate (CAGR) of 7.25% during 2024-2032.
• North America leads the market, accounting for the largest inferior vena cava (IVC) filter market share.
• Retrievable IVC filter accounts for the majority of the market share in the product segment as it is designed to be implanted temporarily in patients at high risk of pulmonary embolism. 
• Non-ferromagnetic material holds the largest share in the inferior vena cava (IVC) filter industry.
• Treatment venous thromboembolism (VTE) remains a dominant segment in the market due to the rising focus on reducing the chances of pulmonary embolism.
• Hospitals represent the leading end user segment.
• The rising incidence of venous thromboembolism (VTE) is a primary driver of the inferior vena cava (IVC) filter market.
• Technological advancements in filter design and the increasing awareness and screening initiatives for VTE are reshaping the inferior vena cava (IVC) filter market.

Grab a sample PDF of this report: https://www.imarcgroup.com/inferior-vena-cava-filter-market/requestsample

Industry Trends and Drivers:

• Rising Incidence of Venous Thromboembolism (VTE):

The increasing prevalence of venous thromboembolism, which includes conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE), is a key driver in the inferior vena cava (IVC) filter market. Aging populations, sedentary lifestyles, obesity, and chronic conditions, such as cancer and heart disease, are contributing factors to the rise in VTE cases. There is an increase in the need for preventive measures like IVC filters as these conditions can result in life-threatening complications. Patients at high risk of VTE, especially those who are not ideal candidates for anticoagulants, are often prescribed IVC filters. This growing patient pool is creating a higher demand for these devices because of their ability to provide an effective solution to prevent blood clots from traveling to the lungs.

• Technological Advancements in Filter Design:

Continuous innovations in the design and functionality of IVC filters are impelling the market growth. Manufacturers are developing more innovative filters that are both permanent and retrievable, offering flexibility to physicians based on patient needs. The introduction of minimally invasive (MI) filter placement techniques is reducing the risks associated with filter insertion and retrieval, making them safer and more appealing to both patients and doctors. In addition, newer filters aid in enhancing biocompatibility and reducing the chances of long-term complications, such as device migration or thrombosis. As a result, these improvements assist in increasing physician confidence in the devices, encouraging wider use.

• Increasing Awareness and Screening Initiatives for VTE:

The increasing public health awareness about venous thromboembolism, along with the implementation of medical guidelines and screening programs, is contributing to the market growth. Healthcare institutions and organizations are emphasizing the early detection of deep vein thrombosis and pulmonary embolism, encouraging at-risk patients to undergo screening. This heightened awareness is leading to earlier diagnosis and intervention. Moreover, the rising focus on preventive measures like IVC filters among individuals is bolstering the market growth. Furthermore, professional medical societies and public health campaigns are working to educate both healthcare providers and patients about the risks associated with untreated VTE and the benefits of using IVC filters.

Explore full report with table of contents: https://www.imarcgroup.com/inferior-vena-cava-filter-market

Inferior Vena Cava (IVC) Filter Market Report Segmentation:

Breakup By Product:

• Retrievable IVC Filter
• Permanent IVC Filter

Retrievable IVC filter accounts for the majority of shares as it is designed to be implanted temporarily in patients at high risk of pulmonary embolism.

Breakup By Material:

• Non-Ferromagnetic Material
• Ferromagnetic Materials

Non-ferromagnetic material dominates the market on account of its ability to provide enhanced biocompatibility.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position owing to a large market for inferior vena cava (IVC) filter driven by the presence of well-established healthcare infrastructure.  

Top Inferior Vena Cava (IVC) Filter Market Leaders:

The inferior vena cava (IVC) filter market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• ALN Implants Chirurgicaux
• Argon Medical Devices Inc.
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Braile Biomédica
• Cook Group Incorporated

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145